MY106940A - Allelic variants of plasmodium falciparum merozoite surface antigen. - Google Patents

Allelic variants of plasmodium falciparum merozoite surface antigen.

Info

Publication number
MY106940A
MY106940A MYPI89001311A MYPI19891311A MY106940A MY 106940 A MY106940 A MY 106940A MY PI89001311 A MYPI89001311 A MY PI89001311A MY PI19891311 A MYPI19891311 A MY PI19891311A MY 106940 A MY106940 A MY 106940A
Authority
MY
Malaysia
Prior art keywords
terminal
surface antigen
plasmodium falciparum
merozoite surface
sequences
Prior art date
Application number
MYPI89001311A
Inventor
James Saul Allan
Leon Coppel Ross
Fredric Anders Robin
James Kemp David
Howard Goss Neil
Arthur Smythe Jason
Lloyd Jones Graham
Owen Irving David
Leigh Dyer Sandra
Wai Wing Chee David
Original Assignee
Saramane Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saramane Pty Ltd filed Critical Saramane Pty Ltd
Publication of MY106940A publication Critical patent/MY106940A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A MEROZOITE SURFACE ANTIGEN OF PLASMODIUM FALCIPARUM SELECTED FROM THE CLASS CHARACTERISED BY:(I) HAVING A RELATIVE MOLECULAR MASS, MR, (DETERMINED BY SDS-POLYAERYLAMIDE GEL ELECTROPHORESIS)IN THE RANGE OF APPROXIMATELY 41,000 TO 53,000: AND (II) COMPRISING MULTIPLE ALLELIC FORMS OF MSA2, HAVING CONSERVED N-TERMINAL AND C-TERMINAL SEQUENCES:OR AN ANTIGENIC FRAGMENT THEREOF. PARTICULAR ANTIGENIC FRAGMENTS INCLUDE SEQUENCE CORRESPONDING TO REPEAT SEQUENCES AND SEQUENCES FROM CONSERVED N-TERMINAL AND C-TERMINAL REGIONS. PRODUCTION OF ANTIGENS BY RECOMBINANT DNA TECHNIQUES-AS FUSION AND NON-FUSION PROTEINS, AND USE IN VACCINE COMPOSITIONS IS ALSO DISCLOSED.
MYPI89001311A 1989-08-24 1989-09-22 Allelic variants of plasmodium falciparum merozoite surface antigen. MY106940A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU596289 1989-08-24

Publications (1)

Publication Number Publication Date
MY106940A true MY106940A (en) 1995-08-30

Family

ID=79553926

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89001311A MY106940A (en) 1989-08-24 1989-09-22 Allelic variants of plasmodium falciparum merozoite surface antigen.

Country Status (1)

Country Link
MY (1) MY106940A (en)

Similar Documents

Publication Publication Date Title
DK0423302T3 (en) Use of novel DNA fragments as coding sequence for a signal peptide for secretion of mature proteins in recombinant yeast, expression cassettes, transformed yeast and similar method for producing proteins
DE3588254D1 (en) Gag antigen and its use for the detection of LAV infection, as well as in immunogenic compositions
ATE127345T1 (en) STRESS PROTEINS AND USES THEREOF.
DE69829668D1 (en) PREPARATION AND USE OF RECOMBINANT INFLUENZA A VIRUS M2 CONSTRUCTIONS AND IMPORTS
PT100781A (en) DNA SEQUENCES CODING OF EXTERNAL SURFACE PROTEINS, PROTEINS CONTAINING THE REFERENCED SEQUENCES, OBTAINED FROM BORRELIA BURGDORFERI, AND VACCINES CONTAINING THE REFERRED PROTEINS
PT101052A (en) Hybrid proteins useful in the preparation of vaccines
MX9702714A (en) Production of peptides in plants as viral coat protein fusions.
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
DK0594771T3 (en) Cycloheximide resistance in nucleotide sequences and proteins
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
DE69007571D1 (en) HIV peptide fragments.
ZA896942B (en) Allelic variants of plasmodium falciparum merozoite surface antigen
ES2006730A6 (en) ASEXUAL BLOOD STAGE ANTIGENS OF -i(PLASMODIUM FALCIPARUM).
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
GR3003754T3 (en)
ZA902831B (en) Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p.falciparum at the sporozoite stage and in the hepatocytes
NO20011263L (en) Moraxella Catarrhalis BASBO34 polypeptides and uses thereof
MY103217A (en) Plasmodium falciparum merozoite antigen pertides
KR890000106A (en) Protozoan Parasite Vaccine
ZA907944B (en) Hiv related peptides
FR2665365B1 (en) PLASMODIUM FALCIPARUM ANTIGEN SUSCEPTIBLE TO INDUCE PROTECTIVE ANTIBODIES - APPLICATION TO VACCINATION.
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum